The Alzheimer’s Association is disappointed to learn of the negative interim results from the Phase III clinical trial of Semagacestat. People with Alzheimer’s urgently need more and better treatment options for this devastating, fatal brain disease
Police were looking for a missing Alzheimer’s patient Wednesday. James A
VIRGINIA BEACH-Police need your help as they search for a missing Alzheimer’s patient.
Parkwood Village is hosting a lunch and learn on Thursday, July 29th at 11:30 a.m. The topic will be Alzheimers Caring and Coping. The program will be presented by Kathy Sikes from the Alzheimers Association.
Researchers from the University of Sydney’s Alzheimer’s and Parkinson’s Disease Laboratory have achieved a major breakthrough by finding the causes of Alzheimer’s disease at a cellular level and thereby identifying a potential therapy as a result.
The Alzheimer’s Association has become aware of a misleading message from the CEO of the Alzheimer’s Foundation of America dated July 19, 2010. We deny and dispute all of the allegations against our Association in this letter and in AFA’s lawsuit against us. We are proud of our 30 years of providing care and support to those impacted by Alzheimer’s and advancing critical research
A promising study demonstrated that cholinesterase inhibitors (ChEI), a type of medication often prescribed for Alzheimer’s disease (AD), improved some cognitive skills in patients with mild AD — skills that are necessary for driving. Findings from the study showed that after being treated with a ChEI, AD patients improved in some computerized tests of executive function and visual attention …
WASHINGTON, June 14 Researchers have found that those suffering from Alzheimers disease (AD) can enhance their mood with apple juice.
A promising study from Rhode Island Hospital demonstrated that cholinesterase inhibitors (ChEI), a type of medication often prescribed for Alzheimer’s disease (AD), improved some cognitive skills in patients with mild AD - skills that are necessary for driving. Findings from the study showed that after being treated with a ChEI, AD patients improved in some computerized tests of executive …
Researchers from the University of the Basque Country (UPV/EHU) have found a new Alzheimers-related mechanism that could give rise to the development of new therapies against this disease.
( Elhuyar Fundazioa ) Researchers from the University of the Basque Country have found a new Alzheimer’s-related mechanism that could give rise to the development of new therapies against this disease.
A new report from the Alzheimer’s Association, “Changing the Trajectory of Alzheimer’s Disease: A National Imperative” shows that in the absence of disease-modifying treatments, the cumulative costs of care for people with Alzheimer’s from 2010 to 2050 will exceed $20 trillion, in today’s dollars.
WEDNESDAY, May 19 (HealthDay News) — The number of Americans age 65 and older with Alzheimer’s disease will more than double in the next 40 years, and the cumulative costs of caring for them between now and 2050 will exceed $20 trillion, a new report from the Alzheimer’s Association finds.
Alzheimer’s disease will rack up more than $20 trillion in treatment costs over the next 40 years in the United States, according to a report on Wednesday that calls on Congress to increase funding for drug research.
Harry Smith talks to Robert Egge from the Alzheimer’s Association about their new report card for the disease.
Why can’t they just forgive and forget? The Alzheimer’s Foundation, based in Manhattan, claims the Alzheimer’s Association, based in Chicago, has been poaching donations meant for them, including a $36,000 gift from the estate of a Virginia woman. Mildred Harbaugh’s will specified that 15 percent…
The close-knit siblings began to notice little things about their mother, Roberta Randolph. She started to repeat phrases
Researchers from the National Institute of Health say that there are, as of yet, no known preventive measures which can effectively halt the onset of Alzheimer’s disease.
Florida law firm Ruden McClosky has been plagued by partners leaving, a Ruden lawyer describing firm management as “morons,” a decrease in head count from 175 to about 100, and rumors that the firm will dissolve. Now, an association devoted to the study and treatment of Alzheimer’s disease has filed a lawsuit accusing Ruden and two former firm principals of misappropriating $1.1 million from the …
Progressive dementia of Alzheimer’s patients is due to an inexorable loss of nerve cells from the brain. German neuroscientists have now shown that microglia may actually make a significant contribution to the loss of neurons associated with Alzheimer’s disease.